Global Medical Devices Reimbursement Market 2023-2029

Medical device reimbursement is important because it ensures that patients have access to the medical devices they need. It also ensures that healthcare costs are contained by making sure that medical devices are used in an appropriate and cost-effective manner. The global medical devices reimbursement market is expected to increase by USD 354.4 billion, at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2029, according to the latest edition of the Global Medical Devices Reimbursement Market Report. The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global medical devices reimbursement market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the payers, healthcare setting, and region. The global market for medical devices reimbursement can be segmented by payers: public, private. The private segment captured the largest share of the market in 2022. Medical devices reimbursement market is further segmented by healthcare setting: hospitals, outpatient facilities, others. The hospitals segment held the largest share of the global medical devices reimbursement market in 2022 and is anticipated to hold its share during the forecast period. Based on region, the medical devices reimbursement market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2022, North America made up the largest share of revenue generated by the medical devices reimbursement market. Market Segmentation By payers: public, private By healthcare setting: hospitals, outpatient facilities, others By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America The report also provides a detailed analysis of several leading medical devices reimbursement market vendors that include Aetna Inc., Allianz SE, Anco Insurance Managers, Ltd., Aviva plc, BNP Paribas SA, Centene Corporation, Cigna Corporation, CVS Health Corporation, Elevance Health, Inc., Hamilton Leigh Limited, HUB International Limited, Humana Inc., Nippon Life Insurance Company, North American Science Associates, Inc. (NAMSA), ProAssurance Corporation (Medmarc Insurance Group), Reliance Nippon Life Insurance Company Limited, UnitedHealth Group Incorporated, WellCare Health Plans, Inc., Xifin, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Scope of the Report • To analyze and forecast the market size of the global medical devices reimbursement market. • To classify and forecast the global medical devices reimbursement market based on payers, healthcare setting, region. • To identify drivers and challenges for the global medical devices reimbursement market. • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global medical devices reimbursement market. • To identify and analyze the profile of leading players operating in the global medical devices reimbursement market. Why Choose This Report • Gain a reliable outlook of the global medical devices reimbursement market forecasts from 2023 to 2029 across scenarios. • Identify growth segments for investment. • Stay ahead of competitors through company profiles and market data. • The market estimate for ease of analysis across scenarios in Excel format. • Strategy consulting and research support for three months. • Print authentication provided for the single-user license.